cellfree-rna-agent

<!--

COPYRIGHT NOTICE

This file is part of the "Universal Biomedical Skills" project.

Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>

All Rights Reserved.

#

This code is proprietary and confidential.

Unauthorized copying of this file, via any medium is strictly prohibited.

#

Provenance: Authenticated by MD BABU MIA

-->

---

name: 'cellfree-rna-agent'

description: 'AI-powered cell-free RNA analysis from liquid biopsy for cancer detection, tissue-of-origin identification, and non-invasive transcriptomic profiling.'

measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.

allowed-tools:

• read_file
• run_shell_command

---

Cell-Free RNA Analysis Agent

The Cell-Free RNA Analysis Agent provides comprehensive analysis of circulating cell-free RNA (cfRNA) from plasma and other biofluids for cancer detection, tissue-of-origin identification, and non-invasive transcriptomic profiling.

When to Use This Skill

• When analyzing plasma cfRNA for cancer detection and monitoring.
• To identify tissue-of-origin from circulating transcripts.
• For non-invasive transcriptomic profiling of tumors.
• When integrating cfRNA with cfDNA for comprehensive liquid biopsy.
• To discover RNA-based biomarkers from accessible biofluids.

Core Capabilities

1. cfRNA Profiling: Quantify mRNA, lncRNA, and small RNA from plasma.

1. Tissue Deconvolution: Identify tissue sources contributing to cfRNA pool.

1. Cancer Detection: ML models detecting cancer from cfRNA profiles.

1. Tumor Transcriptomics: Infer tumor gene expression non-invasively.

1. Integration with cfDNA: Combine RNA and DNA liquid biopsy analytes.

1. Biomarker Discovery: Identify diagnostic and prognostic RNA markers.

cfRNA Biology

Sources:

• Cell death (apoptosis, necrosis)
• Active secretion (EVs, RNA-binding proteins)
• Cell surface-associated RNA

Protection Mechanisms:

• Extracellular vesicles
• Protein complexes (AGO2, NPM1)
• Lipoproteins

Half-life: Minutes to hours (shorter than cfDNA)

Workflow

1. Input: Plasma cfRNA sequencing data (total RNA, small RNA, or targeted).

1. Quality Control: Assess library complexity, mapping rates, contamination.

1. Quantification: Normalize and quantify transcripts.

1. Deconvolution: Estimate tissue contributions.

1. Classification: Apply cancer detection models.

1. Integration: Combine with cfDNA if available.

1. Output: Tissue composition, cancer score, biomarker profiles.

Example Usage

User: "Analyze plasma cfRNA to detect cancer and identify tissue of origin."

Agent Action:

python3 Skills/Genomics/CellFree_RNA_Agent/cfrna_analyzer.py \
    --input plasma_cfrna.fastq.gz \
    --protocol total_rna \
    --reference gencode_v44 \
    --deconvolution true \
    --cancer_detection true \
    --output cfrna_results/

Tissue Deconvolution

Reference Transcriptomes:

• GTEx tissue expression atlas
• Single-cell reference atlases
• Tissue-specific marker genes

Methods:

• Non-negative least squares
• Support vector regression
• Deep learning deconvolution

Clinical Applications:

• Organ injury detection (liver, heart, brain)
• Tumor burden estimation
• Post-transplant monitoring

Cancer Detection Applications

| Cancer Type | Key Markers | Performance |

|-------------|-------------|-------------|

| Lung | XIST, MALAT1, specific mRNAs | AUC 0.80-0.90 |

| Breast | HER2, ER/PR transcripts | Monitoring |

| Colorectal | KRAS, panel genes | Early detection |

| Prostate | PCA3, TMPRSS2-ERG | Established |

| Liver | AFP, specific ncRNAs | HCC surveillance |

Technical Considerations

Pre-analytical Factors:

• Sample collection (EDTA, cell stabilization)
• Processing time (<4 hours recommended)
• Storage temperature (-80°C)
• Hemolysis avoidance (critical)

Library Preparation:

• Total RNA (captures mRNA, lncRNA)
• Small RNA (miRNA, piRNA)
• Targeted panels (specific genes)
• UMI-based for quantification

AI/ML Components

Cancer Classifier:

• Gradient boosting on gene panels
• Neural networks for full transcriptome
• Multi-cancer detection models

Tissue Predictor:

• Reference-based deconvolution
• Supervised tissue classifiers
• Anomaly detection for novel sources

Integration with Other Analytes

| Analyte | Strength | Combination Benefit |

|---------|----------|---------------------|

| cfDNA | Mutations, methylation | Genomic + transcriptomic |

| CTCs | Single-cell analysis | Cellular confirmation |

| Exosomes | Protected RNA | Source identification |

| Proteins | Functional markers | Multi-modal biomarkers |

Prerequisites

• Python 3.10+
• STAR/Salmon for alignment
• DESeq2/edgeR for quantification
• Tissue deconvolution tools

Related Skills

• Liquid_Biopsy_Analytics_Agent - For comprehensive liquid biopsy
• Exosome_EV_Analysis_Agent - For EV-derived RNA
• ctDNA_Analysis - For DNA-based markers

Emerging Technologies

1. Targeted cfRNA: Gene panels for specific cancers
2. Single-molecule: Direct RNA sequencing
3. Spatial deconvolution: Mapping cfRNA to tissue regions
4. Longitudinal monitoring: Treatment response tracking

Author

AI Group - Biomedical AI Platform

<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->